GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers
GSK1838705A 抑制胰岛素样生长因子 1 受体和间变性淋巴瘤激酶，并在人类癌症实验模型中表现出抗肿瘤活性
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-09-0423
Peter Sabbatini, Susan Korenchuk, Jason L Rowand, Arthur Groy, Qi Liu, Dominic Leperi, Charity Atkins, Melissa Dumble, Jingsong Yang, Kelly Anderson, Ryan G Kruger, Richard R Gontarek, Kenneth R Maksimchuk, Sapna Suravajjala, Russell R Lapierre, J Brad Shotwell, Joseph W Wilson, Stanley D Chamberlai
信号转导
肿瘤
淋巴瘤
Insulin Receptor
Human
